Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas

IntroductionAggressive prolactinomas (APRLs) pose a significant clinical challenge due to their high rate of regrowth and potentially life-threatening complications. In this study, we present a case of a patient with an APRL who had a trial of multiple therapeutic modalities with the aim to provide...

Full description

Bibliographic Details
Main Authors: Eduardo J. Medina, Youssef M. Zohdy, Edoardo Porto, Juan M. Revuelta Barbero, David Bray, Justin Maldonado, Alejandra Rodas, Miguel Mayol, Bryan Morales, Stewart Neill, William Read, Gustavo Pradilla, Adriana Ioachimescu, Tomas Garzon-Muvdi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Endocrinology
Subjects:
aggressive
atypical
prolactinoma pituitary adenomas
pazopanib
molecular biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1195792/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1195792/full

Similar Items